Who
Adora Ndu
Director
Company insider
Files Form 4 as: Director, ACADIA Pharmaceuticals; Director, DBV Technologies.
In numbers
- Trades disclosed
- 26
- Buys
- 1
- Sells
- 0
- Bought
- $1,624
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Jun 2021
- Last trade
- 29 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 May 2026filed 1 Jun 2026 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —8,107 | filing |
| 29 May 2026filed 1 Jun 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,107 at $0.00 | filing |
| 29 May 2026filed 1 Jun 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —16,004 at $0.00 | filing |
| 29 May 2026filed 1 Jun 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,107 at $0.00 | filing |
| 29 May 2026filed 1 Jun 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —16,004 at $0.00 | filing |
| 29 May 2026filed 1 Jun 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,311 at $0.00 | filing |
| 29 May 2026filed 1 Jun 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,311 at $0.00 | filing |
| 29 May 2026filed 1 Jun 2026 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —8,107 | filing |
| 29 May 2025filed 2 Jun 2025 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —9,387 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —13,793 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —8,107 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —9,387 | filing |
| 12 Oct 2024filed 15 Oct 2024 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,381 at $0.00 | filing |
| 12 Oct 2024filed 15 Oct 2024 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —4,381 | filing |
| 29 May 2024filed 31 May 2024 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,652 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —15,959 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,387 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —6,652 | filing |
| 6 Feb 2024filed 8 Feb 2024 | DBVT DBV TechnologiesBiotechnology | SEC FORM 4 Bought | $1,6241,825 at $0.89 | filing |
| 12 Oct 2023filed 16 Oct 2023 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,381 at $0.00 | filing |
News
Head-To-Head Review: DBV Technologies (NASDAQ:DBVT) vs. Arrowhead Pharmaceuticals (NASDAQ:ARWR)DBVT · dailypolitical.com · 21 Oct 2026DBV Technologies (NASDAQ:DBVT) Sets New 52-Week Low – What's Next?DBVT · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name Adora Ndu; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.